These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9555800)

  • 1. Regression of Kaposi's sarcoma during therapy with HIV-1 protease inhibitors: a prospective pilot study.
    Krischer J; Rutschmann O; Hirschel B; Vollenweider-Roten S; Saurat JH; Pechère M
    J Am Acad Dermatol; 1998 Apr; 38(4):594-8. PubMed ID: 9555800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of highly active antiretroviral therapy on AIDS-associated Kaposi's sarcoma.
    Dupin N; Rubin De Cervens V; Gorin I; Calvez V; Pessis E; Grandadam M; Rabian C; Viard JP; Huraux JM; Escande JP
    Br J Dermatol; 1999 May; 140(5):875-81. PubMed ID: 10354025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acquired immunodeficiency syndrome-related Kaposi's sarcoma regression after highly active antiretroviral therapy: biologic correlates of clinical outcome.
    Cattelan AM; Calabrò ML; Gasperini P; Aversa SM; Zanchetta M; Meneghetti F; De Rossi A; Chieco-Bianchi L
    J Natl Cancer Inst Monogr; 2001; (28):44-9. PubMed ID: 11158206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-4 in the treatment of AIDS-related Kaposi's sarcoma.
    Tulpule A; Joshi B; DeGuzman N; Espina BM; Mocharnuk R; Prakash O; Templeton D; Levine AM; Gill PS
    Ann Oncol; 1997 Jan; 8(1):79-83. PubMed ID: 9093711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of protease inhibitor-based highly active antiretroviral therapy on survival in HIV-associated advanced Kaposi's sarcoma patients treated with chemotherapy.
    Leitch H; Trudeau M; Routy JP
    HIV Clin Trials; 2003; 4(2):107-14. PubMed ID: 12671778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of regimens based on non-nucleoside reverse transcriptase inhibitors or protease inhibitors in preventing Kaposi's sarcoma.
    Portsmouth S; Stebbing J; Gill J; Mandalia S; Bower M; Nelson M; Bower M; Gazzard B
    AIDS; 2003 Jul; 17(11):F17-22. PubMed ID: 12853764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcomes of HIV-infected patients with Kaposi's sarcoma receiving nonnucleoside reverse transcriptase inhibitor-based antiretroviral therapy in Uganda.
    Asiimwe F; Moore D; Were W; Nakityo R; Campbell J; Barasa A; Mermin J; Kaharuza F
    HIV Med; 2012 Mar; 13(3):166-71. PubMed ID: 22112164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different impact of anti-retroviral regimen containing protease inhibitors on development of HIV-related Kaposi sarcoma.
    Carleo MA; Di Martino F; Del Giudice A; Gargiulo M; Parrella G; Rosario P; Sangiovanni V; Viglietti R; Esposito V; Chirianni A
    In Vivo; 2015; 29(1):133-6. PubMed ID: 25600542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma.
    Bihl F; Mosam A; Henry LN; Chisholm JV; Dollard S; Gumbi P; Cassol E; Page T; Mueller N; Kiepiela P; Martin JN; Coovadia HM; Scadden DT; Brander C
    AIDS; 2007 Jun; 21(10):1245-52. PubMed ID: 17545700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy of ritonavir in the prevention of AIDS-related Kaposi's sarcoma.
    Stebbing J; Portsmouth S; Nelson M; Mandalia S; Kandil H; Alexander N; Davies L; Brock C; Bower M; Gazzard B
    Int J Cancer; 2004 Feb; 108(4):631-3. PubMed ID: 14696132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Remission from Kaposi's sarcoma on HAART is associated with suppression of HIV replication and is independent of protease inhibitor therapy.
    Martinez V; Caumes E; Gambotti L; Ittah H; Morini JP; Deleuze J; Gorin I; Katlama C; Bricaire F; Dupin N
    Br J Cancer; 2006 Apr; 94(7):1000-6. PubMed ID: 16570046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [HIV protease inhibitors for the treatment of Kaposi's sarcoma].
    Grosso G; Sgadari C; Barillari G; Toschi E; Bacigalupo I; Carlei D; Palladino C; Baccarini S; Malavasi L; Moracci G; Leone P; Chiozzini C; Monini P; Ensoli B
    Recenti Prog Med; 2003 Feb; 94(2):69-74. PubMed ID: 12908373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regression of AIDS-related Kaposi's sarcoma following antiretroviral therapy with protease inhibitors: biological correlates of clinical outcome.
    Cattelan AM; Calabro ML; Aversa SM; Zanchetta M; Meneghetti F; De Rossi A; Chieco-Bianchi L
    Eur J Cancer; 1999 Dec; 35(13):1809-15. PubMed ID: 10673996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of Kaposi's sarcoma-associated herpesvirus in peripheral blood cells in human immunodeficiency virus infection: association with Kaposi's sarcoma, CD4 cell count, and HIV RNA levels.
    Min J; Katzenstein DA
    AIDS Res Hum Retroviruses; 1999 Jan; 15(1):51-5. PubMed ID: 10024052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AIDS-related Kaposi's sarcoma patients with visceral manifestations. Response to human chorionic gonadotropin preparations.
    Hermans P; Clumeck N; Picard O; van Vooren JP; Duriez P; Zucman D; Bryant JL; Gill P; Lunardi-Iskandar Y; Gallo RC
    J Hum Virol; 1998; 1(2):82-9. PubMed ID: 10195236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response to: a retrospective analysis of AIDS-associated Kaposi's sarcoma in patients with undetectable HIV viral loads and CD4 counts greater than 300 cells/mm(3).
    Maurer T; Leslie K; Unemori P
    J Int Assoc Physicians AIDS Care (Chic); 2010; 9(2):73. PubMed ID: 20484734
    [No Abstract]   [Full Text] [Related]  

  • 17. Virologic and immunologic parameters that predict clinical response of AIDS-associated Kaposi's sarcoma to highly active antiretroviral therapy.
    Pellet C; Chevret S; Blum L; Gauvillé C; Hurault M; Blanchard G; Agbalika F; Lascoux C; Ponscarme D; Morel P; Calvo F; Lebbé C
    J Invest Dermatol; 2001 Oct; 117(4):858-63. PubMed ID: 11676823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolated penile Kaposi's sarcoma in a HIV-positive patient stable on treatment for three years.
    Lebari D; Gohil J; Patnaik L; Wasef W
    Int J STD AIDS; 2014 Jul; 25(8):607-10. PubMed ID: 24492851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relapse of Kaposi's Sarcoma and HHV-8 viremia in an HIV-infected patient switching from protease inhibitor to integrase inhibitor-based antiretroviral therapy.
    Simonetti FR; Ricaboni D; Cattaneo D; Micheli V; Rusconi S; Gervasoni C
    J Clin Virol; 2016 Jan; 74():75-7. PubMed ID: 26682615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AIDS presenting with cutaneous Kaposi's sarcoma and bacillary angiomatosis in the bone marrow mimicking Kaposi's sarcoma.
    Rosales CM; McLaughlin MD; Sata T; Katano H; Veno PA; de Las Casas LE; Miranda RN
    AIDS Patient Care STDS; 2002 Dec; 16(12):573-7. PubMed ID: 12542930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.